巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Palatin Technologies

    PTN
    0.363
    0.000
    0.72%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Palatin Technologies - 延遲價格・最後更新於 27/05 10:00
    最高位
    0.368
    最低位
    0.361
    開市價
    --
    前收市價
    0.360
    成交量(千)
    2.60
    成交額(百萬)
    0.01
    買入
    --
    賣出
    5.000
    每手股數
    --
    市值(百萬)
    84.04
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    0.960 - 0.315
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Palatin Technologies
    證券代碼
    PTN.US
    所屬板塊
    Biotechnology
    公司業務
    Palatin Technologies Inc is a part of the healthcare sector. The company is engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with unmet medical needs and commercial potential. Its programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Its main product in clinical development is bremelanotide, which treats hypoactive sexual desire disorder, which is a type of female sexual dysfunction.
    發行量
    231258137
    公司總部
    4B Cedar Brook Drive
    公司網址
    https://www.palatin.com
    公司電郵
    investors@palatin.com
    公司電話
    +1 609 495-2200
    暫無內容

    關於

    Palatin Technologies(PTN.US)所屬的行業板塊為Biotechnology。
    Palatin Technologies Inc is a part of the healthcare sector. The company is engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with unmet medical needs and commercial potential. Its programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Its main product in clinical development is bremelanotide, which treats hypoactive sexual desire disorder, which is a type of female sexual dysfunction.
    詳細公司背景可參考: https://www.palatin.com